Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Drug developer Novavax Inc. (NASDAQ: NVAX) said its third-quarter loss narrowed slightly on lower expenses following staff cuts and other cost cutting, according to Associated Press. Full Article at TransWorldNews